Aims: The associations between the number of antihypertensive agents being taken by type 2 diabetic patients and 1) the grade of atherosclerosis according to non-invasive surrogate markers for atherosclerosis and 2) the other risk factor for atherosclerosis, were cross-sectionally investigated. Methods: The association between the blood pressure control and the clinical characteristics was evaluated in 1359 patients with type 2 diabetes mellitus. Results: The number of antihypertensive agents was 1.5 ± 1.4 (2.0 ± 1.2 among the 990 patients with hypertension). The proportion of patients taking no antihypertensive agents was 29%, 22% were taking one, 29% were taking two and 21% of the patients were taking three or more antihypertensive agents. The value of the ankle-brachial pressure index significantly decreased with the increase in the number of antihypertensive agents even if the blood pressure was corrected to the target value. The values of brachial-ankle pulse wave velocity and carotid intima-media thickness were also increased. The prevalence of risk factors for atherosclerosis, such as obesity, hyperlipidemia, chronic kidney disease, hyperuricemia and anemia was significantly elevated with the number of agents. Conclusions: The number of antihypertensive agents simply reflects the grade and risk of atherosclerosis in patients with type 2 diabetes mellitus.
It is well-recognized that atherosclerotic diseases are common in patients with type 2 diabetes mellitus. Hypertension is not only an independent risk factor for atherosclerosis, but is also common in the type 2 diabetic patients [1,2]. Furthermore, hypertension is a risk factor for the onset and progression of diabetic microand macrovascular complications, as well as hyperglycemia [3,4]. The risk for cardiovascular events synergistically increases in patients with both diabetes mellitus and hypertension [
In the present cross-sectional study, the associations between the number of antihypertensive agents being used by patients with type 2 diabetes mellitus and 1) the grade of atherosclerosis according to non-invasive surrogate markers for atherosclerosis and 2) the other risk factors for atherosclerosis were investigated. We consider that these results indicate the necessity of a more aggressive approach for the diabetic patients requiring intensive therapy for hypertension independently from the blood pressure control.
A population of 2107 patients diagnosed with type 2 diabetes mellitus who underwent consecutive treatments in the Department of Diabetes, Metabolism and Kidney Disease of Edogawa Hospital, Tokyo, Japan between April 2008 and March 2011, were screened for this study. For diagnosis of chronic kidney disease (CKD), 89 patients without urinalysis findings were excluded from the study. Because it is considered that a certain amount of time is required to adjust the dosage of antihypertensive agents, 653 subjects who were treated for less than 12 months were excluded from the study. Also excluded were 6 subjects whose blood pressure data were absent from their medical records following 12 months of treatment in our department. Finally, the associations between the number of antihypertensive agents being used and the clinical characteristics of the patients were evaluated in 1359 subjects who were treated for more than 12 months in the present cross-sectional study.
The blood pressure was measured twice with the subjects in the sitting position after a 5 minute rest. The lower value of the two measurements was used for the study. Hypertension was defined as a SBP ≥140 mmHg and/or a DBP ≥90 mmHg. The participants currently using antihypertensive medications were also classified as positive for hypertension. The diagnosis of hypertension for this cross-sectional study was performed according to the medical records at the final visit to our hospital. The target blood pressure was less than 130/80 mmHg according to the JNC7 [
The patients were divided into two categories according to their blood pressure status. Categories 1 and 2 were defined to include the subjects showing 1) SBP <130 mmHg and DBP <80 mmHg and 2) SBP ≥130 mmHg or DBP ≥80 mmHg, respectively.
The number of antihypertensive agents was expressed as the sum of the antihypertensive agents, such as thiazide diuretics, loop diuretics, aldosterone antagonists, alpha blockers, beta blockers, calcium channel blockers (CCBs), angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), renin inhibitors, and centrally-acting adrenergic drugs that were being used.
The obese individuals were defined as those having a body mass index ≥25.0 kg/m2.
The serum total cholesterol, LDL-cholesterol, HDLcholesterol and uric acid concentrations were measured with a TBA-200 FR NEO device using the Determiner L TC II, Determiner L LDL-C, Determiner L HDL-C and Determiner L UA instruments (Kyowa Medex Co., Ltd., Tokyo, Japan). Hyperlipidemia was defined by serum concentrations of total cholesterol ≥5.7 mmol/L, a LDLcholesterol level ≥3.6 mmol/L, or as patients who were already undergoing treatment with lipid-lowering agents. The triglyceride concentrations were not investigated in this study because fasting blood samples could not always be obtained for measurements. Hyperuricemia was defined by serum uric acid levels >416 μmol/L or as patients using allopurinol according to the guidelines proposed by the Japanese Society of Gout and Nucleic Acid Metabolism [
Anemia was defined as a hemoglobin level <135 g/L in men and 120 g/L in women according to the guidelines of the European Renal Association-European Dialysis and Transplantation Association [
The estimated glomerular filtration rate (eGFR) was calculated using the formula reported by Matsuo, et al. [
CKD was defined as a decreased eGFR (<60 mL/min/ 1.73 m2) and/or a urinary albumin-to-creatinine ratio (ACR) >30 mg/g creatinine [18,19].
The HbA1c levels were determined by a high performance liquid chromatography method using an automated HLC-723G7 analyzer (Tosoh Corporation, Tokyo, Japan) and calibrated by the Japan Diabetes Society (JDS) standard calibrators.
The ankle-brachial pressure index (ABI) and brachialankle pulse wave velocity (baPWV), as indicators of atherosclerosis, were measured using a Form PWV/ABI, BP-203PRE II instrument (Omron Colin Co., Ltd, Bunkyo, Tokyo, Japan). The intima-media thickness (IMT) of the carotid artery was measured via ultrasonographic examinations by skilled laboratory technicians using an Aplio XV ultrasound machine (Toshiba Medical Systems Corp., Ohtawara, Tochigi, Japan) as described previously [
This study was conducted according to the principles expressed in the 2008 Declaration of Helsinki. The Ethics Committee of Edogawa Hospital approved the protocol of this study and waived the need for written informed consent because the data were analyzed anonymously for this cross-sectional study based on the data stored in the hospital database.
All data are shown as the means ± SD. The KruskalWallis test and the χ2 test were used for among-group comparisons of the continuous and categorical variables, respectively. A stepwise multivariate analysis by the forward selection method was performed to determine the association of the value of surrogate markers with the risk factors for atherosclerosis. Differences of P < 0.05 (two-tailed) were considered to be statistically significant. The statistical software package JMP, version 8.0 (SAS Institute, Cary, NC, USA), was used to perform all of the analyses.